Can the model for end-stage liver diseas
โ
Sarwa Darwish Murad; W. Ray Kim; Piet C. de Groen; Patrick S. Kamath; Michael Ma
๐
Article
๐
2007
๐
John Wiley and Sons
๐
English
โ 213 KB
๐ 1 views
The model for end-stage liver disease (MELD) is a widely accepted and objective scoring system for end-stage liver disease (ESLD) but has never been evaluated for Budd-Chiari syndrome (BCS). We investigated whether MELD can be used to predict survival in patients with BCS. Patients with BCS (n ฯญ 237